相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease
Niklas Mattsson et al.
JAMA NEUROLOGY (2019)
Age-Dependent Relationship Between Plasma Aβ40 and Aβ42 and Total Tau Levels in cognitively Normal Subjects
Lih-Fen Lue et al.
FRONTIERS IN AGING NEUROSCIENCE (2019)
The Past and the Future of Alzheimer's Disease Fluid Biomarkers
Kaj Blennow et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease
Che-Chuan Yang et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Plasma Amyloid-beta (A beta(42)) Correlates with Cerebrospinal Fluid A beta(42) in Alzheimer's Disease
Charlotte E. Teunissen et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
High performance plasma amyloid-β biomarkers for Alzheimer's disease
Akinori Nakamura et al.
NATURE (2018)
The Relation Between Brain Amy o d Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer's Disease
Ling-Yun Fan et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Physical activity can improve cognition in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials
Zhen Du et al.
CLINICAL INTERVENTIONS IN AGING (2018)
Plasma α-synuclein predicts cognitive decline in Parkinson's disease
Chin-Hsien Lin et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2017)
Association between cerebrospinal fluid and plasma neurodegeneration biomarkers with brain atrophy in Alzheimer's disease
Joana B. Pereira et al.
NEUROBIOLOGY OF AGING (2017)
Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer's Dementia: Findings in Two Cohorts
Lih-Fen Lue et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Brain atrophy in Alzheimer's Disease and aging
Lorenzo Pini et al.
AGEING RESEARCH REVIEWS (2016)
The Presence of Select Tau Species in Human Peripheral Tissues and Their Relation to Alzheimer's Disease
Brittany N. Dugger et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Bob Olsson et al.
LANCET NEUROLOGY (2016)
Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
Matthew R. Brier et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Plasma β-amyloid in Alzheimer's disease and vascular disease
Shorena Janelidze et al.
SCIENTIFIC REPORTS (2016)
Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials
Michael C. Donohue et al.
ALZHEIMERS & DEMENTIA (2015)
Plasma Aβ but Not Tau is Related to Brain PiB Retention in Early Alzheimer's Disease
Kai-Yuan Tzen et al.
ACS CHEMICAL NEUROSCIENCE (2014)
Plasma tau as a window to the brainnegative associations with brain volume and memory function in mild cognitive impairment and early alzheimer's disease
Ming-Jang Chiu et al.
HUMAN BRAIN MAPPING (2014)
Mild Cognitive Impairment and Mild Dementia: A Clinical Perspective
David S. Knopman et al.
MAYO CLINIC PROCEEDINGS (2014)
Combined Plasma Biomarkers for Diagnosing Mild Cognition Impairment and Alzheimer's Disease
Ming-Jang Chiu et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Potential Blood Biomarker for Disease Severity in the Taiwanese Population With Alzheimer's Disease
Ching-Wen Huang et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS (2013)
Plasma tau levels in Alzheimer's disease
Henrik Zetterberg et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
Definitions of dementia and predementia states in Alzheimer's disease and vascular cognitive impairment: consensus from the Canadian conference on diagnosis of dementia
Howard Chertkow et al.
ALZHEIMERS RESEARCH & THERAPY (2013)
CSF p-Tau levels in the prediction of Alzheimer's disease
Ramesh J. L. Kandimalla et al.
BIOLOGY OPEN (2013)
New Assay for Old Markers-Plasma Beta Amyloid of Mild Cognitive Impairment and Alzheimer's Disease
M. J. Chiu et al.
CURRENT ALZHEIMER RESEARCH (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Multi-Channel SQUID-Based Ultra-High-Sensitivity In-Vitro Detections for Bio-Markers of Alzheimer's Disease Via Immunomagnetic Reduction
M. J. Chiu et al.
IEEE TRANSACTIONS ON APPLIED SUPERCONDUCTIVITY (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Magnetically enhanced high-specificity virus detection using magnetic nanoparticles with antibodies as labeling markers
S. Y. Yang et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease
Kaj Blennow et al.
NATURE REVIEWS NEUROLOGY (2010)
Assessment of β-amyloid deposits in human brain: a study of the BrainNet Europe Consortium
Irina Alafuzoff et al.
ACTA NEUROPATHOLOGICA (2009)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Neuropsychological Assessment of Dementia
David P. Salmon et al.
ANNUAL REVIEW OF PSYCHOLOGY (2009)
Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia
Sabrina Ravaglia et al.
NEUROLOGICAL SCIENCES (2008)
Human brain myelination and amyloid beta deposition in Alzheimer's disease
George Bartzokis et al.
ALZHEIMERS & DEMENTIA (2007)
Cerebrospinal fluid tau, Aβ, and phosphorylated tau protein for the diagnosis of Alzheimer's disease
Patrizia Formichi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Magnetic susceptibility reduction method for magnetically labeled immunoassay
Chin-Yih Hong et al.
APPLIED PHYSICS LETTERS (2006)
CSF amyloid-β-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia
M Bibl et al.
BRAIN (2006)
分享论文
